Molecular characterization of blaKHM-1 encoding plasmid in an Enterobacter hormaechei subsp. hoffmannii isolate from blood culture.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 19 09 2019
accepted: 23 12 2019
entrez: 14 1 2020
pubmed: 14 1 2020
medline: 15 4 2020
Statut: epublish

Résumé

KHM-1 was first reported in 1997 in Japan as a novel metallo-β-lactamase mediated by Citrobacter freundii carrying pKHM-1 plasmid. There have been few reports in the clinical field since then. A blaKHM-1-positive Enterobacter hormaechei subsp. hoffmannii in E. cloacae complex, isolate OIPH-N069 was isolated from an inpatient blood culture in 2016. The isolate was characterized by whole-genome sequencing, comparative analysis of the blaKHM-1 encoding plasmid, antimicrobial susceptibility tests, and bacterial conjugation. OIPH-N069 was classified into ST78 of E. cloacae complex, and was multidrug resistant because of the presence of antimicrobial resistance genes in addition to blaKHM-1 on its chromosome and plasmids. blaKHM-1 was located on 136,816 bp of the IncA/C2 plasmid pN069-1, which could be transferred to different bacterial species. The backbone structure, genetic arrangement of the class 1 integron cassette, and the blaKHM-1 gene located downstream of the IncA/C2 antibiotic resistance island, ARI-A, in pN069-1 and pKHM-1 were identical. Horizontal gene transfer of the blaCTX-M-2-ISEcp1 resistance gene module only occurred with pN069-1. The study findings indicate not only the structural conservation of blaKHM-1 encoding plasmids over time and across species, but also the risk of the spread of blaKHM-1 encoding plasmids to other bacterial species and the accumulation of additional resistance genes.

Identifiants

pubmed: 31929575
doi: 10.1371/journal.pone.0227605
pii: PONE-D-19-26475
pmc: PMC6957179
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0227605

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
PLoS One. 2017 Sep 14;12(9):e0184720
pubmed: 28910381
Antimicrob Agents Chemother. 2012 Dec;56(12):6437-40
pubmed: 23070158
Antimicrob Agents Chemother. 2016 Jul 22;60(8):5068-71
pubmed: 27246777
Clin Microbiol Infect. 2012 Mar;18(3):268-81
pubmed: 21793988
Exp Ther Med. 2017 Mar;13(3):1117-1126
pubmed: 28450951
Front Microbiol. 2019 Jan 31;10:44
pubmed: 30766518
BMC Genomics. 2011 Aug 08;12:402
pubmed: 21824423
Virulence. 2017 May 19;8(4):460-469
pubmed: 27593176
Antimicrob Agents Chemother. 2014 Jul;58(7):3895-903
pubmed: 24777092
Int J Syst Evol Microbiol. 2007 Jan;57(Pt 1):81-91
pubmed: 17220447
Int J Syst Evol Microbiol. 2014 Feb;64(Pt 2):346-51
pubmed: 24505072
mBio. 2016 Dec 13;7(6):
pubmed: 27965456
Bioinformatics. 2009 Apr 15;25(8):1096-8
pubmed: 19228805
Front Microbiol. 2019 Jan 30;10:80
pubmed: 30761114
F1000Res. 2018 May 01;7:521
pubmed: 30430006
J Antimicrob Chemother. 2012 Nov;67(11):2640-4
pubmed: 22782487
Jpn J Infect Dis. 2012;65(3):252-5
pubmed: 22627309
PLoS Comput Biol. 2017 Jun 8;13(6):e1005595
pubmed: 28594827
Antimicrob Agents Chemother. 2015 Feb;59(2):1356-9
pubmed: 25487806
Bioinformatics. 2018 Mar 15;34(6):1037-1039
pubmed: 29106469
Int J Antimicrob Agents. 2016 Feb;47(2):158-62
pubmed: 26795022
mSphere. 2019 Sep 25;4(5):
pubmed: 31554719
Antimicrob Agents Chemother. 2008 Nov;52(11):4194-7
pubmed: 18765691
Antimicrob Agents Chemother. 2018 Feb 23;62(3):
pubmed: 29311089
Plasmid. 2015 Jul;80:63-82
pubmed: 25910948
J Antibiot (Tokyo). 2019 Feb;72(2):79-85
pubmed: 30361635
J Clin Microbiol. 2012 Apr;50(4):1355-61
pubmed: 22238442
Bioinformatics. 2011 Apr 1;27(7):1009-10
pubmed: 21278367

Auteurs

Kaoru Umeda (K)

Division of Microbiology, Osaka Institute of Public Health, Osaka, Japan.

Hiromi Nakamura (H)

Division of Microbiology, Osaka Institute of Public Health, Osaka, Japan.

Akira Fukuda (A)

Division of Microbiology, Osaka Institute of Public Health, Osaka, Japan.

Takahiro Yamaguchi (T)

Division of Microbiology, Osaka Institute of Public Health, Osaka, Japan.

Yuki Matsumoto (Y)

Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Daisuke Motooka (D)

Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Shota Nakamura (S)

Genome Information Research Center, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Ryuji Kawahara (R)

Division of Microbiology, Osaka Institute of Public Health, Osaka, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH